Navigation Links
FDA Approves Injectable Gel to Treat Fecal Incontinence
Date:5/27/2011

SILVER SPRING, Md., May 27, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Fecal incontinence is the involuntary loss of bowel control. It can have different causes including nerve damage, weakened anal sphincter associated with aging, or rectum muscle damage. According to the National Institutes of Health, there are more than 5.5 million Americans with fecal incontinence.

The Solesta gel is injected into a layer of tissue beneath the anus lining and may help build tissue in that area. By growing the surrounding tissue, the opening of the anus narrows and the patient may be able to better control those muscles.

"Fecal incontinence is difficult to treat," said Christy Foreman, director of the Office of Device Evaluation at the FDA's Center for Devices and Radiological Health. "This approval provides a minimally invasive treatment option for patients with fecal incontinence that does not respond to conservative therapies."

The FDA based its approval on results from a clinical study of 206 patients. In the primary study, most patients received two treatments, consisting of four injections each, for a total of eight injections. After six months, more than half of the patients injected with Solesta experienced a 50 percent reduction in the number of fecal incontinence episodes. However, one-third of patients who received no Solesta in the study also experienced a similar reduction. Overall, a greater proportion of patients treated with Solesta experienced improvements, indicating the gel provides benefit.  

Solesta is approved for use in patients ages 18 and up. It should not be used in patients who h
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA approves Incivek for hepatitis C
2. FDA Approves Sutent for Rare Type of Pancreatic Cancer
3. FDA Approves New HIV Treatment
4. FDA Approves Victrelis for Hepatitis C
5. FDA Approves New Treatment for Rare Type of Pancreatic Cancer
6. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
7. FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
8. FDA Approves New Treatment for Type 2 Diabetes
9. FDA Approves Zytiga for Late-Stage Prostate Cancer
10. FDA Approves Updated, Clarified Indication for Use for iFuse Implant System®
11. FDA Approves Lamictal®XR™ (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... THE WOODLANDS, Texas , March 2, 2015 /PRNewswire/ ... ), a biopharmaceutical company focused on developing breakthrough treatments ... year end 2014 financial results on Wednesday, March 4, ... hold a conference call and webcast to discuss clinical ... and year end of 2014 at 10:00 a.m. Eastern ...
(Date:3/2/2015)... LOS ANGELES , March 2, 2015 ImmunoCellular Therapeutics, ... report financial results for the year ended December 31, 2014 on ... update conference call and webcast on Thursday, March 12, 2015, at ... Gengos , President and CEO.   , ... international dial-in: (631) 291-4544; conference code 92238648. , , , ...
(Date:3/1/2015)... , March 1, 2015 /CNW Telbec/ -   Ergoresearch ... Laval and known under the « Équilibre, ... for the second quarter Ended on December 31, 2014. ... Canadian currency. Revenues for the second ... 31, 2014 totaled $ 4 095 112 decreasing by 8,8 % compared ...
Breaking Medicine Technology:Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 2ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 3Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 4
(Date:3/2/2015)... What are the best practices for ... When are interviews scheduled, how can physicians best prepare, ... and practicing physicians who are looking for new opportunities ... at the PracticeLink Physician Career Advancement Workshop and Job ... is from 5:30 to 8:30 p.m. at the Marriott-Texas ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Éminence Organic ... skin care, is excited to announce the launch of ... provide an effective, time-saving solution for those with combination ... 2 in 1 divided jar to separate the products, ... Cheek Treatment. The Balancing Moisturizer Duo, also in a ...
(Date:3/1/2015)... 2015 Security Life Insurance Company ... market, announced the addition of stand-alone individual vision ... Insurance launched today, complete with two plan options. ... the VSP® Vision Care network encompassing a strong ... space. The PrimeStar Select Vision plan will use ...
(Date:3/1/2015)... Comparing a new source of vehicle insurance ... Pros portal this year. A broad range of agencies ... are being supplied through the finder at http://quotespros.com/auto-insurance.html ... available for each policy is now provided in exchange ... will first be asked to present their unique zip ...
(Date:3/1/2015)... Ticket Down is a reputable source for authentic ... Field. Deadheads have been anxiously anticipating this blockbuster weekend ... was formed 50 years ago back in the 60s in ... the untimely death of Jerry Garcia in 1995. This ... reggae, rock, bluegrass, folk, space rock and country to become ...
Breaking Medicine News(10 mins):Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 3Health News:Security Life Insurance Company Launches Individual Vision Insurance Product 2Health News:United Auto Insurance Rates Now Quoted at Consumer Insurance Portal Online 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2
... for injuries to the white and gray matter of ... Certain forms of these injuries can be detected in ... Medical Center researchers. Researchers who followed a ... those with neonatal ultrasound abnormalities were at increased risk ...
... (HealthDay News) -- An international team of researchers has identified ... legs syndrome. Restless legs syndrome is a condition in ... the legs, relieved only by movement. One of the most ... loss, daytime fatigue and even depression. In the ...
... we eat more food, but according to new study in ... to eating lessin restaurant settings. "In this research we ... quantity of food consumed," write authors Arul Mishra, Himanshu Mishra, ... City). The authors conducted a field study in a ...
... By Dennis Thompson HealthDay Reporter , WEDNESDAY, ... have taken a hard line against air traffic controllers ... improve air safety, sleep experts say. Studies have ... improving reaction time and critical thinking for people impaired ...
... transplant survival more than doubled in recent years for ... Research Hospital, with patients who lacked genetically matched donors ... to be the best ever reported for leukemia patients ... expected to make transplantation a treatment option for more ...
... initiative, the American Society for Radiation Oncology (ASTRO) has developed ... papers, on the safe use of integrating intensity modulated radiation ... of this white paper is published in the July print ... The full text of the document is available in advance ...
Cached Medicine News:Health News:Abnormal brain ultrasounds in premature infants indicate future risk of psychiatric disorders 2Health News:Size matters: Why do people eat less when they have big forks? 2Health News:Sometimes Sleeping on the Job May Be a Good Thing 2Health News:Sometimes Sleeping on the Job May Be a Good Thing 3Health News:Bone marrow transplant survival more than doubles for young high-risk leukemia patients 2Health News:Bone marrow transplant survival more than doubles for young high-risk leukemia patients 3Health News:ASTRO publishes white paper on IMRT safety 2
For the quantitative determination of Creatine Kinase in serum....
For the quantitative determination of creatine kinase in serum. Kinetic Reaction measured at 340 nm. Linearity: 1500 IU/L at 37C....
For the quantitative determination of total glucose in serum....
Intended for the quantitative determination of glucose in serum. Reaction: endpoint. Wavelength: 500 nm. Linearity: 500 mg/dL (27.8 mmol/L)....
Medicine Products: